Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

CNTB
Connect Biopharma Holdings Limited
stock NASDAQ

At Close
Aug 4, 2026 3:59:39 PM EDT
2.08USD+5.330%(+0.11)267,724
0.00Bid   0.00Ask   0.00Spread
Pre-market
Aug 4, 2026 8:25:30 AM EDT
2.07USD+5.076%(+0.10)500
After-hours
Aug 4, 2026 4:00:30 PM EDT
2.07USD-0.241%(-0.01)18,153
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 24, 2022
07:07AM EST  Connect Biopharma Presents Data And Analyses From The Global Phase 2b Trial Of CBP-201 At The Maui Derm Conference   Benzinga
07:00AM EST  Data provides detailed results, with achievement of both primary and key secondary end points and demonstrating significant improvements in skin clearance, disease severity, and itch compared to placebo   GlobeNewswire Inc
Jan 13, 2022
12:55PM EST  Connect Biopharma's Latest Dermatitis Drug Update Fails to Pump Up Shares   Benzinga
Jan 6, 2022
08:02AM EST  10 Biggest Price Target Changes For Thursday   Benzinga
04:35AM EST  SVB Leerink Maintains Outperform on Connect Biopharma Hldgs, Lowers Price Target to $22   Benzinga
Jan 5, 2022
08:20AM EST  The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets   Benzinga
07:04AM EST  Connect Biopharma Reports Detailed Dataset From Global Phase 2b Trial Of CBP-201 In Adult Patients With Moderate-To-Severe Atopic Dermatitis   Benzinga
07:00AM EST  Phase 2b trial previously reported achievement of both primary and key secondary end points, demonstrating significant improvements in skin clearance, disease severity, and itch compared to placebo   GlobeNewswire Inc
Jan 4, 2022
04:05PM EST  Connect Biopharma to Host Conference Call on January 5 at 8:30 AM   GlobeNewswire Inc
Nov 22, 2021
08:27AM EST  Connect Biopharma Appoints Mr. Steven Chan As Chief Financial Officer   Benzinga
08:00AM EST  Connect Biopharma Expands Executive Leadership Team with Hire of   GlobeNewswire Inc
Nov 21, 2021
03:05PM EST  The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week   Benzinga
Nov 19, 2021
02:47PM EST  Mid-Afternoon Market Update: Dow Falls 200 Points; Connect Biopharma Shares Tumble   Benzinga
12:07PM EST  Mid-Day Market Update: Crude Oil Down Over 4%; UWM Holdings Shares Surge   Benzinga
10:19AM EST  Mid-Morning Market Update: Markets Mixed; Foot Locker Profit Beats Views   Benzinga
08:20AM EST  The Daily Biotech Pulse: Connect Biopharma Sinks On Eczema Drug Readout, Enanta Pulls Plug On HBV Drug, Clinical Setback For Merck In HIV Trial   Benzinga
08:01AM EST  Connect Biopharma Completes Enrollment Of CBP-307 Global Phase 2 Clinical Trial In Moderate-To-Severe Ulcerative Colitis   Benzinga
08:00AM EST  Connect Biopharma Completes Enrollment of CBP-307 Global Phase 2   GlobeNewswire Inc
Nov 18, 2021
04:06PM EST  Connect Biopharma Reports Top-Line Results From Global Phase 2 Trial Of CBP-201 In Patients With Moderate-To-Severe Atopic Dermatitis: Primary Endpoint Met   Benzinga
04:02PM EST  Primary endpoint met with all three CBP-201 arms achieving significant improvements   GlobeNewswire Inc
Nov 11, 2021
08:00AM EST  Connect Biopharma to Participate at Upcoming Conferences   GlobeNewswire Inc
Oct 19, 2021
08:00AM EDT  Connect Biopharma to Participate at the Jefferies Virtual China   GlobeNewswire Inc
Sep 8, 2021
08:19AM EDT  Connect Biopharma Announces First Subject Dosed In Phase 2 Trial Evaluating CBP-201 In Adult Patients With Chronic Rhinosinusitis With Nasal Polyps   Benzinga
08:00AM EDT  Connect Biopharma Announces First Subject Dosed in Phase 2 Trial   GlobeNewswire Inc
Sep 2, 2021
08:02AM EDT  Connect Biopharma Announces First Patient Dosed In China Pivotal Trial Evaluating CBP-201 in Adults With Moderate-To-Severe Atopic Dermatitis   Benzinga
08:00AM EDT  Connect Biopharma Announces First Patient Dosed in China Pivotal   GlobeNewswire Inc
Aug 31, 2021
04:08PM EDT  Connect Biopharma H1 2021 R&D Expenses $(33.71M)   Benzinga
04:05PM EDT  - On Track to Report CBP-201 Phase 2B Top-Line Data Evaluating Moderate-to-Severe Atopic Dermatitis (AD) in Q4 of 2021 -   GlobeNewswire Inc
08:15AM EDT  The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical   Benzinga
Aug 29, 2021
09:48AM EDT  The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In a Light Week   Benzinga
Aug 25, 2021
08:00AM EDT  Connect Biopharma to Host First Half 2021 Financial Results   GlobeNewswire Inc
Aug 23, 2021
04:05PM EDT  Connect Biopharma Hires General Counsel & Chief Compliance Officer   GlobeNewswire Inc
Aug 11, 2021
08:14AM EDT  The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering   Benzinga
Jul 7, 2021
07:41AM EDT  The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend   Benzinga
Jul 2, 2021
10:08AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For July 2, 2021   Benzinga
05:49AM EDT  CICC Initiates Coverage On Connect Biopharma Hldgs with Outperform Rating, Announces Price Target of $27   Benzinga
Jun 3, 2021
08:23AM EDT  The Daily Biotech Pulse: Merck Completes Organon Spin-Off, Auris Repositions As RNA Therapeutic Company With Trasir Purchase, Replimune's Readout   Benzinga
May 26, 2021
08:00AM EDT  Connect Biopharma to Participate at the Jefferies Virtual   GlobeNewswire Inc
May 25, 2021
08:01AM EDT  Connect Biopharma Announces First Subject Dosed In Phase I Trial Evaluating Safety, Tolerability And Pharmacokinetic Profile Of CBP-174 In Healthy Adult Subjects   Benzinga
08:00AM EDT  Development program exploring the potential of CBP-174 in the treatment of chronic inflammatory pruritus   GlobeNewswire Inc
May 13, 2021
08:10AM EDT  The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use   Benzinga
May 12, 2021
08:57AM EDT  The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron   Benzinga
08:09AM EDT  Connect Biopharma Announces First Patient Doses In Phase 2 Trial Evaluating CBP-201 In Adults With Moderate-To-Severe Persistent Asthma   Benzinga
08:00AM EDT  Connect Biopharma Announces First Patient Dosed in Phase 2 Trial   GlobeNewswire Inc
May 11, 2021
07:54AM EDT  The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings   Benzinga
Apr 13, 2021
12:07PM EDT  Connect Biopharma shares were trading higher after multiple firms initiated coverage on the stock with a bullish rating.   Benzinga
10:06AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2021   Benzinga
08:18AM EDT  Jefferies Initiates Coverage On Connect Biopharma Hldgs with Buy Rating, Announces Price Target of $27   Benzinga
07:18AM EDT  SVB Leerink Initiates Coverage On Connect Biopharma Hldgs with Outperform Rating, Announces Price Target of $32   Benzinga
Apr 10, 2021
09:19AM EDT  The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight   Benzinga
Apr 8, 2021
08:20AM EDT  Connect Biopharma Completes Enrollment Of CBP-201 Global Phase 2 Clinical Trial In Moderate-to-Severe Atopic Dermatitis   RTTNews
08:00AM EDT  Connect Biopharma Completes Enrollment of CBP-201 Global Phase 2   GlobeNewswire Inc
Mar 26, 2021
07:28AM EDT  The Daily Biotech Pulse: FDA Nod For Astellas, Seagen, Gilead Get Positive Regulatory Tidings From Europe, 3 IPOs   Benzinga
Mar 25, 2021
07:58AM EDT  The Daily Biotech Pulse: Bristol-Myers Squibb's Skin Cancer Readout, Cellect Strikes Reverse Merger Deal, Lava Therapeutics Makes Nasdaq Debut   Benzinga
Mar 24, 2021
08:59AM EDT  The Daily Biotech Pulse: Dynavax-Clover Start Phase 2/3 Vaccine Study. BrainStorm Reports Positive MS Readout, NeoGenomics Goes Shopping   Benzinga
Mar 23, 2021
04:05PM EDT  Connect Biopharma Holdings Limited Announces Closing of Initial   GlobeNewswire Inc
Mar 22, 2021
12:28PM EDT  The IPO Market Had A Busy Week   Benzinga
Mar 19, 2021
10:16AM EDT  Connect Biopharma Shares Open For Trade At $19.55; IPO Priced At $17/Share   Benzinga
09:27AM EDT  Connect Biopharma Shares Will Open For Quote At 9:50 a.m. EDT, Expected To Open For Trade After 10:00 a.m. EDT; IPO Priced At $17/Share   Benzinga
Mar 18, 2021
11:59PM EDT  Connect Biopharma Holdings Limited announces pricing of Initial   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC